InsiderTrades.com logo
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
From Weiss Ratings   |   Ad
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
Learn these 4 simple steps and protect your savings before it’s too late.

IRD Insider Trading

Insider Ownership Percentage: 6.60%
Insider Buying (Last 12 Months): $101,097.06
Insider Selling (Last 12 Months): $0.00

Opus Genetics Insider Trading History Chart

This chart shows the insider buying and selling history at Opus Genetics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Opus Genetics Share Price & Price History

Current Price: $0.88
Price Change: ▼ Price Decrease of -0.03 (-3.28%)
As of 11/19/2024 01:00 AM ET

This chart shows the closing price history over time for IRD up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
This company will win the AI race
From Porter & Company   |   Ad
Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.
You must read this new presentation from Porter Stansberry.

Opus Genetics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2024George MagrathCEOBuy9,706$1.02$9,900.12492,950View SEC Filing Icon  
11/15/2024George MagrathCEOBuy90,294$1.01$91,196.94483,244View SEC Filing Icon  
See Full Table
Financial Prophecy
From Porter & Company   |   Ad
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Including the name of the #1 company to buy.

SEC Filings (Institutional Ownership Changes) for Opus Genetics (NASDAQ:IRD)

14.97% of Opus Genetics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Opus Genetics Inc. is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc., formerly known as Ocuphire Pharma Inc., is based in Farmington Hills, Michigan.
Read More on Opus Genetics

Today's Range

Now: $0.88
Low: $0.85
High: $0.94

50 Day Range

MA: N/A

52 Week Range

Now: $0.88
Low: $0.85
High: $3.40

Volume

244,421 shs

Average Volume

173,676 shs

Market Capitalization

$27.89 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.22

Who are the company insiders with the largest holdings of Opus Genetics?

Opus Genetics' top insider shareholders include:
  1. George Magrath (CEO)
Learn More about top insider investors at Opus Genetics.
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
From Weiss Ratings   |   Ad
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
Learn these 4 simple steps and protect your savings before it’s too late.